The following clinical trials are associated with Breast Cancer.
- collapse A Prospective, Multicenter, Non-interventional Study to Evaluate Quality of Life in Chinese Postmenopausal HR(+) EBC Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
- collapse Non-interventional report on parameters of accepatability, efficacy and compliance of fulvestrant in post-menopausal patients with advanced breast cancer HR positive who progresses to one prior endocrine therapy with antiestrogens.
- collapse Faslodex Post Marketing Surveillance
- collapse The effect of inhaled budesonide and placebo on the development of emphysema in smokers with chronic obstructive pulmonary disease assessed by computer tomography (CT)
- collapse A prospective observational study of compliance in the patients receiving aromatase inhibitor as an adjuvant therapy in postmenopausal early breast cancer.
- collapse An observational study of adherence to adjuvant anastrozole therapy in postmenopausal patients with early breast cancer over one year follow-up.
- collapse A survey conducted to evaluate and assess the factors influencing therapeutic adherence among early breast cancer patients treated with the aromatase inhibitor ARIMIDEX
- collapse Arimidex: Compliance and arthralgias in clinical therapy (COMPACT): An in practice assessment of arthralgias and related costs as well as compliance in the first year of anastrozole therapy
- collapse Breast Cancer Tumorcare Observation Progamme
- collapse Phase II, Open Label, Non-Randomized Study of AZD2281 in the Treatment of Patients with Known BRCA or Recurrent High Grade Serous/ Undifferentiated Tubo-Ovarian Carcinoma and in Known BRCA or Triple Negative Breast Cancer to Determine Response Rate and Correlative Markers of Response
